Scientists discover and characterize a selective hCYP11B2 PET tracer for primary hyperaldosteronism Aug. 31, 2021
Phase I trial evaluates [11C]YJH-08 PET imaging of GR expression in metastatic prostate cancer Aug. 26, 2021
Labile iron pool radiotracer [18F]TRX can predict sensitivity to iron-targeted tumor therapies Aug. 6, 2021
89Zr-Immuno-PET using bispecific Abeta MAb as promising diagnostic strategy for Alzheimer's disease Aug. 5, 2021
Clarity initiates phase I/IIa theranostic trial of 64/67Cu SAR-bisPSMA in metastatic CRPC July 29, 2021
RSS